| |
| |
|
| Insider
Information: |
Sinskey Anthony J |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
584,291 |
|
|
Indirect Shares
|
446,889 |
|
|
| Direct
Value |
$6,352,877 |
|
|
|
Indirect Value
|
$5,974,455 |
|
|
| Total
Shares |
1,031,180 |
|
|
| Total
Value |
$12,327,332 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
8
|
0
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
5
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -19.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Yield10 Bioscience Inc |
YTEN |
Director |
2024-03-28 |
64,274 |
2012-05-21 |
49,346 |
Premium* |
|
|
Apex Bioventures Acquisition Corp |
PEX.WS |
Director |
2007-06-07 |
97,474 |
|
0 |
Premium* |
|
|
Merrimack Pharmaceuticals Inc |
MACK |
Director |
2014-12-18 |
422,543 |
2014-05-13 |
397,543 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2024-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
20,561 |
64,274 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2023-12-29 |
4 |
A |
$0.00 |
$0 |
D/D |
16,275 |
43,713 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2023-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
11,955 |
27,438 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2023-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,759 |
15,483 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2023-01-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
12,309 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2022-08-17 |
4 |
B |
$2.80 |
$5,599 |
D/D |
2,000 |
17,309 |
2.39 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2022-08-16 |
4 |
B |
$2.85 |
$5,698 |
D/D |
2,000 |
15,309 |
2.39 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2022-08-15 |
4 |
B |
$2.77 |
$5,530 |
D/D |
2,000 |
13,309 |
2.39 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2022-03-14 |
4 |
B |
$6.23 |
$6,230 |
D/D |
1,000 |
11,309 |
2.39 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2021-12-13 |
4 |
B |
$5.25 |
$10,500 |
D/D |
2,000 |
10,309 |
2.39 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2021-12-10 |
4 |
B |
$4.89 |
$9,780 |
D/D |
2,000 |
8,309 |
2.39 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2021-12-09 |
4 |
B |
$4.99 |
$9,980 |
D/D |
2,000 |
6,309 |
2.39 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2021-12-03 |
4 |
B |
$4.33 |
$8,660 |
D/D |
2,000 |
4,309 |
2.39 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2021-12-02 |
4 |
B |
$4.63 |
$9,256 |
D/D |
2,000 |
2,309 |
2.39 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2017-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
28,274 |
100,664 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2015-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
12,500 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
Director |
– • – |
2014-12-18 |
4 |
S |
$10.31 |
$206,200 |
D/D |
(20,000) |
422,543 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
Director |
– • – |
2014-12-18 |
4 |
OE |
$1.71 |
$34,200 |
D/D |
20,000 |
442,543 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
Director |
– • – |
2014-08-25 |
4 |
OE |
$1.25 |
$31,250 |
D/D |
25,000 |
422,543 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
Director |
– • – |
2014-05-13 |
4 |
B |
$6.74 |
$33,700 |
I/I |
5,000 |
397,543 |
2.1 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
Director |
– • – |
2013-11-29 |
4 |
B |
$3.92 |
$14,877 |
D/D |
3,800 |
392,543 |
2.39 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
Director |
– • – |
2013-04-24 |
4 |
OE |
$2.19 |
$32,850 |
D/D |
15,000 |
388,743 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
Director |
– • – |
2012-09-07 |
5 |
GA |
$0.00 |
$0 |
I/I |
32,776 |
373,743 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
Director |
– • – |
2012-09-07 |
5 |
GA |
$0.00 |
$0 |
D/D |
16,185 |
340,967 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
Director |
– • – |
2012-09-07 |
5 |
GD |
$0.00 |
$0 |
I/I |
81,736 |
324,782 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
